When do myopia genes have their effect? Comparison of genetic risks between children and adults by Tideman, J. Willem L. et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/94676/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Tideman, J. Willem L., Fan, Qiao, Polling, Jan Roelof, Guo, Xiaobo, Yazar, Seyhan, Khawaja,
Anthony, Höhn, René, Lu, Yi, Jaddoe, Vincent W.V., Yamashiro, Kenji, Yoshikawa, Munemitsu,
Gerhold-Ay, Aslihan, Nickels, Stefan, Zeller, Tanja, He, Mingguang, Boutin, Thibaud, Bencic,
Goran, Vitart, Veronique, Mackey, David A., Foster, Paul J., MacGregor, Stuart, Williams, Cathy,
Saw, Seang Mei, Guggenheim, Jeremy Andrew and Klaver, Caroline C. W. 2016. When do myopia
genes have their effect? Comparison of genetic risks between children and adults. Genetic
Epidemiology 40 (8) , 756 -766. 10.1002/gepi.21999 file 
Publishers page: http://dx.doi.org/10.1002/gepi.21999 <http://dx.doi.org/10.1002/gepi.21999>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
For Peer Review





	





	 	


 

	 
 !"#!	 $
%"&'	 (#")"*"
%)+",*"
%)#",
-).* ,/%) ,

0,)'*"
%)+",
)1!* 2 34)"'  )
 '
"5%" * 2 3%
3 #
* 2 34) 
%%'  
26) *&)34'
789)*34'%"!#, '%
#)
"'0!:#0"%
:;)<*34
#%
6)"'
+",*34=)"'
+",
&)2*.
=,'
#) 
##)>*"
#%)"'#",*
"
#%)"'0#
2")79*734# '
#)
"'+",#> 
2?8)
"*34# '
#)
"'+",#> 
#)*34
#%
6)'
#
=)#",#'"
/?) '*34
#%
6)"'
+",
@)(9*34:%:"!,)%'#
4%#,
:)
,,,* 2 34
=)(!#*'#

#)
#
%:"3
=)* '
34:)"'
+",
>)>A*34'#!,)
%:"3
%




?)4#*34')%'+",
#> )&
-)0*/:="#%BC# ("BC
/: -#(#7,BC%,*
'#:/: 
-#(

,) *.
=,'
#)
=!:) 
")%*34'= ' #%""
John Wiley & Sons, Inc.
Genetic Epidemiology
For Peer Review

#
 8) ,
*/34' ,#/34
: ")+",*?/34' ,)
#
# * ,) ,
/%* 8 8:? '0!:)/
34' ,#/34: "
,,")"* '+"5> 
74)%*"
#%)"'#",*
"
#%)+",
7#	 ")#4"),?) /0



Page 1 of 65
John Wiley & Sons, Inc.
Genetic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
1 
 
	


 
J.W.L. Tideman1,2, Q. Fan3, J.R. Polling1,4, X. Guo5,6,7, S. Yazar8, A. Khawaja9, R. Höhn10,11,  Yi 
Lu12, V.W.V. Jaddoe2, , K. Yamashiro13, M. Yoshikawa13, A. Gerhold1Ay14, S. Nickels10,T. 
Zeller15, M. He16,17, T. Boutin18, G. Bencic19, V. Vitart18, D.A. Mackey20, P.J. Foster21, S. 
MacGregor12, C. Williams22, S.M. Saw3,23, J.A. Guggenheim24,25, C.C.W. Klaver1,2,25 and the 
CREAM consortium 
1 Erasmus Medical Center, Department of Ophthalmology  2 Erasmus Medical Center, Department of Epidemiology 3 Singapore 
Eye Research Institute, Singapore National Eye Centre, Singapore 4 School of Applied Science Utrecht, Department of 
Orthoptics 5 Sun Yat-Sen University, Department of Statistical Science, School of Mathematics & Computational Science 6 SYSU-
CMU Shunde International Joint Research Institute 7 Southern China Research Center of Statistical Science, Sun Yat-Sen 
University, Guangzhou, GD 510275, China 8 Lions Eye Institute, University of Western Australia, Centre for Ophthalmology and 
Visual Science 9 Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of 
Clinical Medicine, Cambridge, United Kingdom. 10 University Medical Center, Department of Ophthalmology, Mainz, Germany  
11 Department of Ophthalmology, Inselspital, Bern, Switzerland 12 Statistical Genetics, QIMR Berghofer Medical Research 
Institute, Brisbane, Australia 13 Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of 
Medicine, Kyoto, Japan  14 University Medical Center Mainz, Institute of Medical Biostatistics, Epidemiology and Informatics, 
Mainz, Germany 15 University Heart Center Hamburg, Clinic for General and Interventional Cardiology, Hamburg, Germany 16 
Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 17 State 
Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China 18 Medical 
Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 
2XU, UK 19 Department of Ophthalmology, Sisters of Mercy University Hospital, Zagreb, Croatia 20 Centre for Ophthalmology 
and Visual Science, Lions Eye Institute, University of Western Australia 21 9 NIHR Biomedical Research Centre, Moorfields Eye 
Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, United Kingdom22 School of Social and Community 
Medicine, University of Bristol, Bristol, England 23 National university of Singapore Saw Swee Hock School of Public 
Health,Singapore Eye Research Institute, Singapore National Eye Centre, Singapore 24 School of Optometry & Vision Sciences, 
Cardiff University, Cardiff, Wales 25 These authors jointly led this work 
 
 
Conflict of Interest: The authors have indicated they have no potential conflicts of interest to disclose 
 
 
 
 
 
 
 

  
Prof. Dr. Caroline C.W. Klaver, MD, PhD, Erasmus Medical Centre 1 Sophia Children's Hospital, 
AL2808; PO Box 2060, 3000 CB Rotterdam, the Netherlands.  
E1mail: c.c.w.klaver@erasmusmc.nl
Page 2 of 65
John Wiley & Sons, Inc.
Genetic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
 
!
: Previous studies have identified many genetic loci for refractive error and myopia. We 
aimed to investigate the effect of these loci on ocular biometry as a function of age in children, 
adolescents and adults.  
": The study population consisted of three age1groups identified from the international 
CREAM consortium: 5,490 individuals aged <10 years; 5,000 aged 10125 years; and 16,274 
aged >25 years. All participants had undergone standard ophthalmic examination including 
measurements of axial length (AL) and corneal radius (CR). We examined the lead SNP at all 
39 currently known genetic loci for refractive error identified from genome1wide association 
studies (GWAS), as well as a combined genetic risk score (GRS). The beta coefficient for 
association between SNP genotype or GRS versus AL/CR was compared across the 3 age 
groups, adjusting for age, sex, and principal components. Analyses were Bonferroni1corrected. 
 : In the age1group <10 years, 3 loci (	
) were associated with 
AL/CR. In the age1group 10125 years, 4 loci (

) were 
associated; and in adults 20 loci were associated. Association with GRS increased with age; β = 
0.0016 per risk allele ( = 2E108) in <10 years, 0.0033 ( 5E115) in 10125 year1olds, and 
0.0048 ( 1E172) in adults. Genes with strongest effects (, ) had an early effect 
that increased with age.  
: Our results provide insights on the age span during which myopia genes exert 
their effect. These insights form the basis for understanding the mechanisms underlying high 
and pathological myopia. 
 
 
#	: myopia, genetic risk, development, SNPs  


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$% &'($&%
The prevalence of myopia (nearsightedness) has increased dramatically in developed countries 
in recent decades [Bar Dayan, et al. 2005; Vitale, et al. 2009]. Myopia is a complex, 
multifactorial disease with increasing public health burden due to a strong rise worldwide. In 
particular high myopia is associated with blinding complications such as myopic macular 
degeneration, glaucoma and retinal detachment [Curtin and Karlin 1971; McBrien and Gentle 
2003; Saw 2006]. High myopia mostly has its onset in early childhood before age 10 years 
[Fledelius 2000]. 
The eye’s dimensions alter markedly during the peak development phase between birth 
and the late teenage years, ultimately exerting very strong effects on final refractive error (RE) 
in later adult life. A complex process called emmetropisation aims to coordinate ocular 
development, bringing light into clear focus on the retina. Early life myopia is characteristically 
associated with excessive axial length (AL) increase. This results in a mismatch of the optical 
effects of the various refractive components of the eye, resulting in a focal point in front of the 
retina. Such a mismatch can be described by the ratio of AL to corneal radius (CR), AL/CR ratio, 
which has a high correlation with RE [Hashemi, et al. 2013; Ip, et al. 2007] and is independent 
of cycloplegia which may vary between studies.  
Various studies have examined the heritability of myopia showing increased risk for first1
degree relatives of affected individuals [Farbrother, et al. 2004; Guggenheim, et al. 2000] and 
twins [Sanfilippo, et al. 2010; Young, et al. 2007]. Numerous genetic loci that cause familial high 
myopia () have been discovered using linkage analysis [Baird, et al. 2010]. More 
recently, genome wide association studies (GWAS) in large cohorts have been performed to 
identify further determinants for REs in the general population. The first single nucleotide 
polymorphisms (SNPs) identified were near  [Solouki, et al. 2010] and 		[Solouki, 
et al. 2010]. Later many more loci were found in studies of large populations (CREAM; 
23andMe)[Kiefer, et al. 2013; Verhoeven, et al. 2013] [Wojciechowski and Hysi 2013]. 
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All previously published refractive error GWAS studies were performed in cohorts 
enrolling participants aged 25 years and older. We aimed to study the effect size of the 39 
GWAS1identified genetic regions associated with refractive error to date, as a function of age.  
  
")*&'
	
	
We included 18 cohorts from 8 different countries in Europe, Asia and Oceania, with a total of 
5,490 children <10 years, 5,000 individuals of 10125 years, and 16,274 adults, all with 
phenotypic and genome1wide genotypic data available. Details on subject recruitment 
procedures can be found in the supplemental materials. Each study participant was genotyped 
with either an Affymetrix or Illumina SNP array (supplemental table I). All studies were 
conducted according to the Declaration of Helsinki. The studies were approved by the local 
review boards. Written, informed consent for the collection and analysis of measurements of all 
study participants was obtained.  
%!
A total of 39 SNPs were included in this analysis. The SNPs were selected based on their 
known association with RE and myopia in the GWAS carried out by CREAM [Verhoeven, et al. 
2013] and 23andMe [Kiefer, et al. 2013](supplementary table II). An unweighted genetic risk 
score (GRS) was calculated for each participant by summing the dosage of risk alleles (scale 01
2) for all 39 SNPs. The risk score was normally distributed.   
&	
The ocular biometry measurements included AL and CR, and the AL/CR ratio was calculated. 
Multiple measurements of AL and CR were taken of the right eye and left eye, were averaged to 
calculate a mean AL and CR for each eye. The average AL of both eyes was divided by the 
average CR of both eyes to calculate the AL/CR ratio. Details of the phenotypic assessment 
protocols/instruments used in each study can be found in the supplemental material. 
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"+	 
All studies performed linear regression models with each SNP or the GRS as determinants, and 
the AL/CR ratio as outcome. Analyses were adjusted for the potentially confounding effects of 
age and gender, and additionally – to account for ancestry differences within the sample – for 
principal components where applicable. A meta1analysis was performed to estimate the beta 
effects using an inversed variance weighted fixed effect model with METAL [Willer, et al. 2010]. 
Meta1analyses were performed in each age stratum separately, and in combined strata of all 
participants <25 years. Several children measured in TEST (Twins Eye Study Tasmania) and 
GTES (Guangzhou Twin Eye Study) had follow up measurements at an older age; therefore, 
only data from the oldest age were used in the combined analysis. In the Asian studies the 
following SNPs were excluded due to low minor allele frequency (MAF) <0.05 in the Chinese 
population: rs17428076, rs1656404, rs14165, rs13091182, rs12205363, rs11145465, 
rs10882165, and rs17183295.
!		
Loci with significant effects (0.05) were further explored to identify differences in effect of 
early1onset genes (significant loci identified in groups <10 years, 10125 years or the combined 
analysis) and late1onset genes (adult subjects). Data were analysed through the use of 
QIAGEN’s Ingenuity® 
 Pathway Analysis  (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) and the online 
software tool Database for Annotation, Visualization and Integrated Discovery (DAVID) [Huang 
da, et al. 2009a; Huang da, et al. 2009b]. 
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 )(,
Our study sample of children <10 years comprised 5,490 participants derived from 5 studies; 
one of European ancestry (TEST), three of Asian ancestry (SCORM, STARS, and Guangzhou 
Twins), and one of mixed European, African, and Asian ancestry (Generation R). Our sample of 
individuals aged 10125 years included 5,000 participants derived from 6 studies; 4 of European 
ancestry (TEST, ALSPAC, BATS and RAINE) , and 2 of Asian (STARS, Guangzhou Twins) 
ancestry. Our sample of adults >25 years compromised 16,274 participants derived from 10 
studies; 9 of European ancestry (Croatia Split, 1Kurcula and – Vis study, Gothenburg Health 
Study, EPIC1Norfolk and the Rotterdam Study I1III), and one Asian study (Nagahama). General 
characteristics per study are shown in Table I. 

-
The genetic risk score was associated with a higher AL/CR ratio even in children aged <10 
years (table II), and this association increased in magnitude with older age. Specifically, AL/CR 
increased with each age category from β 0.0019 (SD 0.0003) per risk allele in children <10 
years, to 0.0033 (SD 0.0004) in participants aged 10125 years, to 0.0051 (SD 0.0003) in adults 
(figure I). Only the adult group showed evidence for heterogeneity (heterogeneity 1value 
0.0005) between studies, therefore, meta1analyses for this age category were also performed 
using the random effect model  (β 0.0048; SD 0.0007; supplementary table IV). The variance 
explained by the genetic risk score increased from 0.7% in the children aged 6 from the 
Generation R study, to 3.7% for the adult participants in the RS I1III (Fig II). 

-
In children <10 years, 9/39 loci were significant at P <0.05, and 3/39 were significant after 
correction for multiple1testing for 39 SNPs (P <0.00128). The 3 loci significant after Bonferroni 
correction were in the vicinity of the genes ,  and 	
. The 2 nominally1significant 
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loci with the greatest effect size (beta) were close to the 	
 and 	 genes. The other 
5 loci were near 

 and . Interestingly,the SNP at the 
 locus had a reversed effect from that observed in adult samples, i.e., the risk allele was 
associated with a lower AL/CR ratio. In individuals aged 10 1 25 years, 10/39 loci showed 
nominally significant association with AL/CR ratio, of which 5 survived Bonferroni correction 
( 
and 
!"Five of the 10 SNPs above were already 
nominal significantly associated with AL/CR ratio in children <10 years (
and	!# of the remaining nominally1significant loci, the variant with the greatest 
effect in 10125 year1olds was the SNP at the locus.One variant differed significantly in 
effect between children <10 years and those aged 10125 years. This was the SNP at the 
locus which, as mentioned above, showed an opposite effect to that expected in children aged 
<10 years (Figure III). One of the loci ( !showed evidence for heterogeneity (supplementary 
table III) in effect between study cohorts in the age category 10125 years (Heterogeneity 
0.001). With random effect model the effect of this SNP decreased to β 0.0062 (SE 0.0073; 
0.40)(supplementary table IV). In the combined analysis of all studies <25 years, and 
	 reached Bonferroni adjusted significance; one additional locus ($! showed a 
nominally significant effect for AL/CR ratio. In adults, 31/39 loci showed a significant effect, of 
which 19/39 were Bonferroni significant. All loci, except for % (β 10.0004; SE 0.0019), 
showed an association in the expected direction (i.e. risk allele associated with a higher AL/CR 
ratio). As in 10125 years, one locus significant in adults showed evidence for heterogeneity 
(LOC100506035); with random effect model this locus lost statistical significance 
(supplementary table III and IV). Figure IV displays all estimated effect sizes per age group.  
!		
Pathway analyses were performed to gain insight into the mechanisms for early versus late1
onset eye growth and myopia development. We hypothesized that loci with at least a moderate 
effect in children and adolescents most likely had an early onset. Hence, a locus was defined as 
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early onset when nominally significant &'"'!in the groups <25 yearsand no evidence for 
heterogeneity (Figure IV; loci above green line). Loci nominally significant in the adult population 
without a significant effect <25 years were grouped as late onset genes (Figure IV; loci below 
green line).  
$	!		.$!/
Genes with an early onset in the age group <25 years were enriched in pathways of auditory 
disease, organismal injury and abnormalities, and gastrointestinal disease (at FDR <5%). The 
genes that were significantly associated in adults predisposed to connective tissue disorders, 
developmental disorder (e.g. microphthalmia; (and  ,), and also gastrointestinal 
disease (supplementary table V).
'012$'	.'1$'/
Using the categories defined above, early1onset genes were annotated to ion channels and ion 
transport (
	

 and 
). Late onset genes appeared to 
be more related to neuron differentiation and visual perception (		 		
)			and	(.) (supplementary table VI). 
 
'$($&% 
This study identifies the age span during which the known GWAS1identified loci for refractive 
error have their greatest effect. The current meta1analysis suggests that specific loci had their 
greatest effect in young children (	

), while others reached the greatest 
effect during early teenage years (
). However, most appeared to have 
a gradual effect during the entire age span of myopia development (		( 
		(		 ).  
Strengths of this study were the large sample size, the comparison across 3 distinct age 
categories, and the precision in measurements of ocular biometry. A drawback was the lack of 
complete cycloplegic refraction in children in several studies, which jeopardized valid 
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measurements of RE in this age category. Thus, we used AL/CR ratio as an indicator of RE to 
avoid heterogeneity in the outcome. This ratio has a high correlation with RE [Hashemi, et al. 
2013; Ip, et al. 2007] and was available from all studies in the consortium. Another limitation 
was the lack of power to detect statistically significant differences between the age groups for 
most genes. A pooled analysis would have increased statistical power, but raw data from 
individual participants were not available. Ideally, a study using longitudinal data of the same 
children over different age periods would have the best study design for the current analysis.  
Little has been reported on the development and progression of myopia as a function of 
age; however, a number of studies investigated the relationship between development of ocular 
biometry related to age. Until the age of 25 years, corneal curvature, the crystalline lens, and 
axial length all evolve with age, and thereby influence refractive error. The cornea increases in 
radius until preschool age leading to flattening of the corneal curvature and decrease in 
refractive power [Augusteyn, et al. 2012]; the crystalline lens grows until 10 years of age, also 
reducing refractive power [Mutti, et al. 2012; Mutti, et al. 1998]. This decrease in refractive 
power is compensated by axial elongation which increases from 17 mm in newborns [Lim, et al. 
2015] to 23.3 mm in 12113 year olds [French, et al. 2012]. The average AL in emmetropic adults 
is 23.5 mm [Fotedar, et al. 2010; Gordon and Donzis 1985]. The highest growth rate of AL 
occurs in the first years of life and relates to emmetropisation; the growth rate after early teens 
is more gradual but mainly relates to myopisation [Gordon and Donzis 1985]. The exact age at 
which eye growth stops is not known; generally this occurs before age 20 years, but increase in 
AL has been described up to the age of 25 years in university students [Fledelius 2000; 
Midelfart, et al. 1992].  
One of the key detected GWAS1identified loci for refractive error is on chromosome 15 
near the  gene, that encodes a gap junction protein known as CX36. This protein not only 
processes cone1to1cone and cone1to1rod signals [Lee, et al. 2003] but also directs signaling 
between other retinal cells [Feigenspan, et al. 2001; Hidaka, et al. 2004]. This cell1to1cell 
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communication appears to be under regulation of light exposure and dopamine [Bloomfield and 
Volgyi 2009], two factors that have an established role in eye growth and myopia development. 
Our data suggest that  has an early1onset, indicating that altered retinal cell signaling, 
perhaps via reduced light exposure and low dopamine levels, may be a first step in myopia 
development. As expected, some early1onset genes also had a reported role in eye 
development. Knockout of a gene encoding the large extracellular glycoprotein laminin1
α2; causes growth retardation including smaller eyes with compressed cellular layers [Gupta, et 
al. 2012]. Mutations in the serine protease gene 	  cause a severe decrease of AL 
leading to microphthalmia [Nair, et al. 2011].  Another developmental gene is  an 
enhancer1binding factor required for embryonic stem cell specification [Luo, et al. 2015]. This 
gene may be important for development of retinal architecture, as it is known to be involved in 
differentiation and proliferation of retinal progenitor cells [Watabe, et al. 2011], and development 
of retinal ganglion cell trajectories [Herrera, et al. 2003]. Strikingly, several other genes involved 
in eye development, such as  ), and  , did not show an early onset but were 
more significant after the age of 10 years. Other early1onset genes were ion channels such as 

, a potassium channel present in cone and rod photoreceptors [Zhang, et al. 2011], and 

, a calcium channel present in photoreceptors [Xiao, et al. 2007]. 	
 has as yet 
an unknown role in myopia development. It encodes the γ subunit of the embryonal 
acetylcholine receptor, which is widely expressed in the retina [Hruska, et al. 1978; Hutchins 
and Hollyfield 1985], and is associated with multiple pterygium syndrome [Vogt, et al. 2012].   
Several remarkable patterns of effect were notable. For instance, the lead SNPs at the 
		, and ( locishowed an opposite effect in children <10 years than 
in those who were older. This is not uncommon in biology, as such a trajectory has also been 
described for the locus in relation to body mass index in children [Sovio, et al. 2011]. 
Interestingly, gene expression studies of  in chickens showed that mRNA of this gene in 
the retinal pigment epithelium is up1 or down1regulated depending on the location of the image 
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plane [Zhang, et al. 2012]. When the image was focused behind the retina, mRNA was 
downregulated and the vitreous chamber enlarged. This underscores a bidirectional role for 
 in modulation of eye growth.   
Most genes had a late onset. ( has a similar function to  as it is also responds 
to optical defocus with bidirectional regulation of eye growth [Zhang, et al. 2013].   is a 
DNA1binding homeobox and has a SIX domain, which binds downstream effector molecules. It 
is known to influence eye size in zebrafish with knocked down  expression [Iglesias, et al. 
2014]. Other genes play a less obvious role in myopiagenesis. MYO1D is involved in membrane 
trafficking in the recycling pathway and expressed in oligodendrites [Benesh, et al. 2012]. 
		a gene encoding a nuclear receptor1directing photoreceptor differentiation, is known to 
activate and generate S1opsin [Jia, et al. 2009; Srinivas, et al. 2006]. DLX1 belongs to the DLX 
family of homeobox transcription factors, and produces GABAergic interneurons during 
embryonic development.  
In conclusion, our study suggests that only a small proportion of the currently known 
GWAS1identified loci for RE exert their full effect at a young age. Furthermore, some of the 
pathways previously1identified by GWAS meta1analyses [Verhoeven, et al. 2013] can now be 
separated into early1 and late1onset pathways. For example, genes coding for ion channels 
typically had an early onset, while genes related to connective tissue and visual feedback 
mechanisms appeared to become more important at a later age. As the currently known genes 
play only a minor role in early1onset myopia, we question whether this type of myopia is caused 
by common variants in other genes, or whether rare variants with large effects determine early1
onset. Future research may shed more light on genes for early1onset myopia, and unravelling 
these genes will open up strategies for prevention of high myopia.  
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Table I Participating studies and characteristics stratified per age group 
*GTES= Guangzhou Twin Eye Study, RS I-III = Rotterdam Study I-III, GHS=Gutenberg Health Study 
 
345	
	 % ,6 .'7/ .'/ -089
STARS 207 2.99 (0.150; 2.76 – 3.46) 5.45 (2.11) 47.3 
Generation R 3,874 2.87 (0.083; 2.38 – 3.90) 6.18 (0.51) 50.3 
SCORM 898 3.02 (0.112; 2.63 – 3.45) 7.48 (0.87) 47.7 
TEST 166 2.94 (0.101; 2.65 – 3.25) 7.53 (1.21) 52.4 
GTES 345 2.97 (0.100; 2.62 – 3.45) 8.73 (0.79) 50.1 
Total :0;<5 
45+=:	
STARS 96 3.23 (0.127; 2.95 – 3.60) 12.23 (1.7) 58.3 
GTES 699 3.13 (0.147; 2.58 – 3.82) 14.83 (1.2) 52.9 
TEST 182 2.99 (0.108; 2.68 – 3.51) 15.16 (4.0) 60.4
ALSPAC 1,996 2.99 (0.099; 2.57 – 3.52) 15.46 (0.3) 53.6 
BATS 983 3.03 (0.106; 2.67 – 3.82) 19.07 (3.2) 53,8
RAINE 1,044 3.05 (0.104; 2.63 – 3.54) 20.04 (0.4) 48.9 
Total :0555 
>=:	
Nagahama 2,762 3.13 (0.153; 2.62 – 3.86) 52.05 (13.8) 49.0 
Croatia1Split 730 3.02 (0.128; 2.38 – 3.90) 52.16 (13.0) 61.2 
Croatia Korcula 832 2.99 (0.203; 2.26 – 5.73) 56.62 (13.3) 64.7 
Croatia1Vis 573 2.99 (0.121; 2.50 – 3.83) 55.93 (13.8) 60.4 
GHS 2 936 3.07 (0.160; 2.50 – 4.01) 59.26 (10.6) 50.0 
GHS 1 1,919 3.06 (0.151; 2.30 – 3.88) 60.17 (10.7) 47.1 
EPIC1Norfolk 6,051 3.05 (0.146; 2.42 – 3.95) 68.9 (8.0) 54.3 
RS I1III 2,471 3.05 (0.143; 2.43 – 3.86) 70.02 (8.8) 53.6 
Total 4?0=@; 
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Table II Effect size of myopia related genes in age groups <10 years, 10-25 years, 25> years 
    
<10 years 10 - 25 years Combined >25 years 
Variant Chr Gene RA Beta (SE) P Beta (SE) P Beta (SE) P Beta (SE) P 
Allele Score - - - 0.0019 (0.0003) 10^-11 0.0033 (0.0004) 10^-15 0.0024 (0.0002) 10^-24 0.0051(0.0003) 10^-72 
rs1652333 1 CD55 G 0.0033 (0.0017) 0.05 0.0006 (0.0024) 0.80 0.0026 (0.0014) 0.07 0.0084(0.0017) 10^-6 
rs4373767 1 ZC3H11B T 0.0010 (0.0017) 0.55 0.0032 (0.0023) 0.16 0.0019 (0.0014) 0.16 0.0053(0.0017) 0.002 
rs17412774 2 PABPCP2 A 0.0007 (0.0017) 0.69 0.0010 (0.0023) 0.67 0.0008 (0.0014) 0.57 0.0063(0.0017) 10^-4 
rs17428076 2 DLX1 C 0.0017 (0.0021) 0.43 0.0029 (0.0027) 0.28 0.0024 (0.0017) 0.16 0.0073(0.0021) 10^-4 
rs1898585 2 PDE11A T 0.0022 (0.0019) 0.26 0.0050 (0.0029) 0.09 0.0034 (0.0017) 0.04 0.0057(0.0021) 0.007 
rs1656404 2 PRSS56 A 0.0073 (0.0024) 0.002 0.0067 (0.0033) 0.04 0.0069 (0.0019) 10^-4 0.0079(0.0024) 0.001 
rs1881492 2 CHRNG T 0.0086 (0.0024) 10^-4 0.0039 (0.0031) 0.21 0.0064 (0.0020) 0.001 0.0085(0.0022) 10^-5 
rs14165 3 CACNA1D G 0.0035 (0.0020) 0.08 0.0082 (0.0026) 0.001 0.0055 (0.0016) 0.001 0.0055(0.0020) 0.005 
rs13091182 3 ZBTB38 G 0.0008 (0.0020) 0.69 -0.0001 (0.0024) 0.98 0.0007 (0.0015) 0.66 -0.0004(0.0019) 0.83 
rs9307551 4 LOC100506035 A 0.0007 (0.0019) 0.70 0.0037 (0.0026) 0.16 0.0020 (0.0016) 0.20 0.0051(0.0020) 0.008 
rs5022942 4 BMP3 A 0.0014 (0.0018) 0.44 -0.0016 (0.0026) 0.54 0.0007 (0.0015) 0.63 0.0006(0.0020) 0.78 
rs7744813 6 KCNQ5 A 0.0050 (0.0017) 0.004 0.0081 (0.0023) 10^-4 0.0060 (0.0014) 10^-5 0.0066(0.0018) 10^-4 
rs12205363 6 LAMA2 T 0.0041 (0.0041) 0.31 0.0138 (0.0046) 0.003 0.0094 (0.0031) 0.003 0.0229(0.0036) 10^-10 
rs7829127 8 ZMAT4 A 0.0025 (0.0020) 0.22 0.0019 (0.0028) 0.49 0.0025 (0.0017) 0.13 0.0072(0.0021) 0.001 
rs7837791 8 TOX G 0.0029 (0.0016) 0.06 0.0083 (0.0022) 10^-4 0.0050 (0.0013) 10^-4 0.0042(0.0017) 0.012 
rs4237036 8 CHD7 T 0.0001 (0.0018) 0.96 0.0032 (0.0024) 0.18 0.0013 (0.0014) 0.37 0.0058(0.0018) 0.001 
rs11145465 9 TJP2 A 0.0035 (0.0022) 0.11 0.0027 (0.0028) 0.33 0.0029 (0.0017) 0.09 0.0062(0.0021) 0.004 
rs7042950 9 RORB G 0.0028 (0.0019) 0.14 0.0031 (0.0026) 0.24 0.0027 (0.0016) 0.08 0.0071(0.0020) 10^-4 
rs7084402 10 BICC1 G 0.0035 (0.0016) 0.03 0.0066 (0.0023) 0.004 0.0050 (0.0013) 10^-4 0.0074(0.0017) 10^-6 
rs6480859 10 KCNMA1 T 0.0040 (0.0018) 0.02 0.0037 (0.0023) 0.10 0.0040 (0.0014) 0.004 0.0015(0.0017) 0.38 
rs745480 10 RGR G 0.0007 (0.0016) 0.67 0.0021 (0.0022) 0.34 0.0011 (0.0013) 0.40 0.0055(0.0017) 0.001 
rs10882165 10 CYP26A1 T 0.0012 (0.0018) 0.49 0.0002 (0.0024) 0.93 0.0007 (0.0014) 0.61 0.0011(0.0018) 0.54 
rs1381566 11 LRRC4C G 0.0026 (0.0020) 0.21 0.0040 (0.0034) 0.23 0.0028 (0.0018) 0.12 0.0093(0.0022) 10^-5 
rs2155413 11 DLG2 A 0.0022 (0.0017) 0.18 0.0027 (0.0022) 0.23 0.0023 (0.0013) 0.09 0.0021(0.0017) 0.21 
rs11601239 11 GRIA4 C 0.0011 (0.0016) 0.50 0.0027 (0.0022) 0.22 0.0014 (0.0013) 0.30 0.0055(0.0017) 0.001 
rs3138144 12 RDH5 G 0.0020 (0.0021) 0.35 0.0039 (0.0027) 0.16 0.0028 (0.0017) 0.10 0.0045(0.0019) 0.02 
rs12229663 12 PTPRR A -0.0023 (0.0019) 0.21 0.0046 (0.0026) 0.08 0.0000 (0.0016) 1.00 0.0069(0.0019) 10^-4 
rs8000973 13 ZIC2 C 0.0058 (0.0017) 10^-4 0.0058 (0.0023) 0.01 0.0059 (0.0014) 10^-5 0.0027(0.0017) 0.10 
rs2184971 13 PCCA A 0.0008 (0.0016) 0.61 0.0006 (0.0023) 0.80 0.0009 (0.0014) 0.48 0.0021(0.0017) 0.21 
rs66913363 14 BMP4 G -0.0025 (0.0017) 0.15 0.0040 (0.0024) 0.10 0.0006 (0.0014) 0.68 0.0047(0.0017) 0.006 
rs1254319 14 SIX6 A 0.0007 (0.0017) 0.68 0.0044 (0.0024) 0.07 0.0017 (0.0014) 0.22 0.0054(0.0018) 0.002 
rs524952 15 GJD2 A 0.0069 (0.0016) 10^-5 0.0068 (0.0023) 0.003 0.0067 (0.0013) 10^-7 0.0122(0.0016) 10^-14 
rs4778879 15 RASGRF1 G 0.0018 (0.0017) 0.29 0.0033 (0.0023) 0.15 0.0019 (0.0014) 0.17 0.0051(0.0017) 0.002 
rs17648524 16 A2BP1 C 0.0018 (0.0018) 0.33 0.0079 (0.0024) 0.001 0.0039 (0.0015) 0.01 0.0077(0.0019) 10^-5 
rs2969180 17 SHISA6 A 0.0035 (0.0016) 0.03 0.0017 (0.0023) 0.46 0.0027 (0.0014) 0.05 0.0079(0.0017) 10^-6 
rs17183295 17 MYO1D T -0.0033 (0.0023) 0.16 0.0009 (0.0030) 0.76 -0.0018 (0.0018) 0.33 0.0089(0.0023) 10^-4 
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Values are betas (SE) and P-values, from linear regression models adjusted for sex, age and principal components if applicable meta-analysed 
with inversed variance meta-analysis in METAL. Bold: P <0.05. 
rs4793501 17 KCNJ2 T 0.0029 (0.0016) 0.08 0.0001 (0.0022) 0.95 0.0019 (0.0013) 0.16 0.0041(0.0017) 0.015 
rs12971120 18 CNDP2 A 0.0002 (0.0019) 0.93 0.0048 (0.0026) 0.07 0.0017 (0.0015) 0.27 0.0024(0.0019) 0.22 
rs235770 20 BMP2 T -0.0043 (0.0018) 0.02 0.0121 (0.0025) 10^-6 0.0008 (0.0015) 0.60 0.0043(0.0017) 0.013 
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9$A Association between genetic risk score and myopia in the three age groups  
9$$A Association between non1weighted genetic risk score and AL/CR ratio in children and adults. 
9$$$A Increased effect on AL/CR ratio with age for  gene. 
9$1A Distribution of effects on AL/CR ratio per myopia1related gene in three age groups 

 


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ALSPAC Illumina HumanHap550  MACH/minimac GIANT phase1 release v3 Cheng et al. 2013 1 
BATS/TEST 
Illumina HumanHap610/6601
Quad 
MACH 
1000G Phase 1 release on Aug 
4, 2010 
Yazar et al. 2015 2 
RAINE Illumina 660W1Quad MACH/minimac 
1000G Phase 1 release on Nov 
23, 2010  
 
Yazar et al. 2015 2 
TEST 
Illumina HumanHap610/6601
Quad 
MACH 
1000G Phase 1 release on Aug 
4, 2010 
Yazar et al. 2015 2 
Generation R 
Illumina Infinium II 
HumanHap610 Quad Arrays 
MACH 1000 Genomes GIANTv3 panel Kruithof et al. 2014 3 
GTES Affymetrix Gene Titan IMPUTE2 v2.3.0 
1000G Phase 1 release on Nov 
23,2010 
 
SCORM Illumina HumanHap550/5501Duo MACH/minimac 
1000G Phase 1 release March 
2012 
Cheng et al. 2013 1 
STARS  Illumina HumanHap6101Quad MACH/minimac 
1000G Phase 1 release March 
2012 
Cheng et al. 2013 1 
GHS 1/2 
Affymetrix Genome1Wide Human 
SNP Array 6.0
MACH/minimac 
1000G Phase 1 release on Nov 
23, 2010 
 
Rotterdam Study 
RS I: Illumina Infinium II 
HumanHap550 chip v3.0 array. 
RS II: HumanHap550  
Duo  Arrays + Human610 ‐
MACH 
NCBI build 36, HapMap release 
#22 
Solouki et al. 20104 
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Quad Arrays Illumina,  
RS1III: Human 610 Quad 
Arrays Illumina 
Croatia 
Korcula: Illumina CNV370v1 and 
CNV370-Quadv3 
Vis: Illumina  HumanHap 300v1 
Split: Illumina CNV370-Quadv3 
and Illumina OmniExpress 
Exome-8v1_A 
IMPUTEv2 
(phasing using 
shapeit v2) 
1000G Phase 1 integrated v3 
release March 2012 (Vis and 
Korcula) release June 2014 
(Split) 
 
 
Nagahama 
Human 610 Quad Arrays 
Illumina / 
Human Omni 2.5 Arrays Illumina 
MACH 
NCBI build 36, HapMap release 
#28 
 
EPIC1Norfolk 
Affymetrix UK Biobank Axiom 
Array.   
IMPUTE version 
2.3.2. 
1000G Phase 3 (October 2014)  
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rs12205363 6 129834628 LAMA2 Verhoeven et al. 2013
rs7829127 8 40726394 ZMAT4 Verhoeven et al. 2013
rs7837791 8 60179086 TOX Verhoeven et al. 2013
rs4237036 8 61701057 CHD7 Verhoeven et al. 2013
rs11145465 9 70989531 TJP2 Verhoeven et al. 2013
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rs10882165 10 94924324 CYP26A1 Verhoeven et al. 2013
rs1381566 11 40149607 LRRC4C Kiefer et al. 2013
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rs2155413 11 84634790 DLG2 Kiefer et al. 2013
rs11601239 11 105556598 GRIA4 Verhoeven et al. 2013
rs3138144 12 56114768 RDH5 Verhoeven et al. 2013
rs12229663 12 71249996 PTPRR Verhoeven et al. 2013
rs8000973 13 100691367 ZIC2 Verhoeven et al. 2013
rs2184971 13 100818092 PCCA Verhoeven et al. 2013
rs66913363 14 54413001 BMP4 Kiefer et al. 2013
rs1254319 14 60903757 SIX6 Verhoeven et al. 2013
rs524952 15 35005885 GJD2 Verhoeven et al. 2013
rs4778879 15 79372875 RASGRF1 Verhoeven et al. 2013
rs17648524 16 7459683 A2BP1 Verhoeven et al. 2013
rs2969180 17 11407901 SHISA6 Verhoeven et al. 2013
rs17183295 17 31078272 MYO1D Verhoeven et al. 2013
rs4793501 17 68718734 KCNJ2 Verhoeven et al. 2013
rs12971120 18 72174023 CNDP2 Verhoeven et al. 2013
rs235770 20 6761765 BMP2 Verhoeven et al. 2013
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    <10 years 10 - 25 years Combined >25 years 
Variant Ch Gene RA Heterogeneity P Heterogeneity P Heterogeneity P Heterogeneity P 
Allele - - - 0.07 0.08 0.0002 0.0005 
rs1652333 1 CD55 G 0.40 0.25 0.23 0.18 
rs4373767 1 ZC3H11B T 0.18 0.69 0.29 0.38 
rs1741277 2 PABPCP2 A 0.50 0.39 0.46 0.25 
rs1742807 2 DLX1 C 0.26 0.02 0.05 0.70 
rs1898585 2 PDE11A T 0.40 0.86 0.76 0.77 
rs1656404 2 PRSS56 A 0.45 0.15 0.25 0.53 
rs1881492 2 CHRNG T 0.69 0.34 0.45 0.95 
rs14165 3 CACNA1D G 0.48 0.70 0.51 0.26 
rs1309118 3 ZBTB38 G 0.13 0.89 0.94 0.16 
rs9307551 4 LOC100506035 A 0.94 0.78 0.92 0.02 
rs5022942 4 BMP3 A 0.82 0.91 0.94 0.98 
rs7744813 6 KCNQ5 A 0.31 0.66 0.53 0.65 
rs1220536 6 LAMA2 T 0.12 0.07 0.06 0.54 
rs7829127 8 ZMAT4 A 0.24 0.75 0.54 0.92 
rs7837791 8 TOX G 0.82 0.001 0.002 0.12 
rs4237036 8 CHD7 T 0.35 0.94 0.84 0.89 
rs1114546 9 TJP2 A 0.17 0.24 0.38 0.13 
rs7042950 9 RORB G 0.83 0.41 0.70 0.12 
rs7084402 10 BICC1 G 0.58 0.38 0.52 0.83 
rs6480859 10 KCNMA1 T 0.27 0.63 0.62 0.81 
rs745480 10 RGR G 0.38 0.88 0.68 0.10 
rs1088216 10 CYP26A1 T 0.51 0.31 0.45 0.03 
rs1381566 11 LRRC4C G 0.40 0.60 0.49 0.78 
rs2155413 11 DLG2 A 0.21 0.52 0.31 0.29 
rs1160123 11 GRIA4 C 0.58 0.96 0.96 0.05 
rs3138144 12 RDH5 G 0.67 0.72 0.83 0.43 
rs1222966 12 PTPRR A 0.41 0.18 0.06 0.97 
rs8000973 13 ZIC2 C 0.44 0.61 0.65 0.01 
rs2184971 13 PCCA A 0.75 0.19 0.37 0.55 
rs6691336 14 BMP4 G 0.62 0.22 0.10 0.57 
rs1254319 14 SIX6 A 0.76 0.24 0.31 0.78 
rs524952 15 GJD2 A 0.73 0.36 0.52 0.49 
rs4778879 15 RASGRF1 G 0.15 0.99 0.79 0.30 
rs1764852 16 A2BP1 C 0.14 0.52 0.07 0.72 
rs2969180 17 SHISA6 A 0.59 0.24 0.30 0.23 
rs1718329 17 MYO1D T 0.47 0.99 0.83 0.37 
rs4793501 17 KCNJ2 T 0.42 0.03 0.03 0.10 
rs1297112 18 CNDP2 A 0.21 0.34 0.22 0.36 
rs235770 20 BMP2 T 0.24 0.67 4*E-5 0.48 
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Supplementary Table IV Random effect analysis of SNPs with P < 0.05 and heterogeneity P <0.05 
    10 - 25 years  >25 years  
Variant Chr Gene RA Effect (SE) P Effect (SE) P 
GRS - - - - - 0.0048 (0.0007) <0.001 
rs9307551 4 LOC100506035 A - - 0.0066 (0.0034) 0.06 
rs7837791 8 TOX G 0.0062 (0.0073) 0.40 - - 
 
GRS = Genetic risk score
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Supplementary table V 
IPA Analysis of diseases and disorders associated with early and late onset genes for myopia with p-
values and molecules 
Diseases and Disorders of early onset genes 
Name p-value range Molecules 
Auditory Disease 1.80E-02 – 1.13E-05 2 
Organismal Injury and Abnormalities 4.62E-02 – 1.13E-05 11 
Gastrointestinal Disease 4.71E-02 – 5.75E-05 8 
Hematological Disease 1.22E-02 – 1.18E-04 3 
Metabolic disease 4.71E-02 – 1.18E-04 3 
   
Diseases and Disorders of late onset genes 
Name p-value range Molecules 
Connective tissue disorders 4.60E-02 – 1.14E-04 4 
Developmental disorders 4.60E-02 – 1.14E-04 7 
Gastrointestinal Disease 4.66E-02 – 1.14E-04 16 
Skeletal and Muscular disorders 4.60E-02 – 1.14E-04 4 
Cancer 4.66E-02 – 8.24E-04 16 
 
Supplementary table VI 
DAVID pathway analysis of functional annotation with early and late onset genes for myopia with p-
values and molecules 
Functional annotation of early onset genes 
GO Term p-value  Molecules 
Channel activity 1.8E-4 5 
Passive transmembrane transporter activity 1.8E-4 5 
Ion channel complex 3.2E-4 4 
Ionic channel 6.7E-4 4 
Cation channel activity 1.0E-3 4 
   
Functional annotation of late onset genes 
GO Term p-value Molecules 
Neurological system process 5.0E-4 7 
Visual perception 1.0E-3 4 
Sensory perception of light stimulus 1.0E-3 4 
Cognition 1.1E-3 6 
Vision 5.8E-3 3 


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Pregnant women with an expected date of delivery between 1st April 1991 and 31st December 
1992, resident in the former Avon health authority area in Southwest England, were eligible to 
participate in this population1based birth cohort study. 13,761 women were recruited. Ethical 
approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local 
Research Ethics Committees. Subject recruitment has been described previously 5. Details of 
the phenotypes available and data access can be found at: 
http://www.bris.ac.uk/alspac/researchers/data1access/data1dictionary/. In brief, data collection 
has been via various methods including self1completion questionnaires sent to the mother, to 
her partner and after age 5 to the child; direct assessments and interviews in a research clinic. 
Ocular biometry (IOLmaster) was carried out when participants attended a research clinic visit 
at the target age of 15 years1old. DNA samples were available for 11,343 ALSPAC Children, 
prepared from either blood samples or lymphoblastoid1transformed cell lines.  
,'%
The Brisbane Adolescent Twin Study is an ongoing study of adolescent and young1adult 
monozygotic (MZ) and dizygotic (DZ) twin pairs (2720 individuals) and their siblings (1179)6. 
Twins were initially recruited to the study from primary and secondary schools in South East 
Queensland in 1992, with new twins added at various intervals. In addition, a small number of 
twins have been recruited through word of mouth, or through the Australian Twin Registry. The 
study was approved by the human research ethics committee at the QIMR Berghofer Medical 
Research Institute. Twins have undergone a variety of phenotypic assessments. A 401ml blood 
sample is collected from participants and parents at the initial assessment. A subset of 
participants also completed an extensive eye examination as part of the Twins Eye Study in 
Tasmania. Axial length was measured using IOLmaster, and corneal curvature was measured 
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using a commercial automatic refractor/keratometer (Humphrey1598 Automatic 
Refractor/Keratometer; Carl Zeiss Meditec, Inc., Miami, FL).  
%-
The Guangzhou Twin Eye Study was launched in 2006, and it has completed eight consecutive 
annual follow1up examinations, with more than 1200 twin pairs participating. In brief, twins born 
in Guangzhou aged 7 to 15 years received annual eye examinations, including  cycloplegic 
refraction, from 2006 onwards. Those with manifest strabismus, amblyopia, nystagmus, post1
refractive surgery, or any ocular disease causing best1corrected visual acuity less than 20/25 
were excluded from the current analysis. The study was conducted in accordance with the 
tenets of the World Medical Association’s Declaration of Helsinki and was approved by the 
Ethics Review Board of the Zhongshan Ophthalmic Center of Sun Yat1Sen University. Written 
informed consent was obtained from the parents or legal guardians of the participants. Axial 
length was measured using the partial coherence interferometry (Zeiss IOLMaster, Jena, 
Germany). Corneal radius was performed under cycloplegia using an auto1refractor (Topcon 
KR8800, Tokyo, Japan). 

Generation R Study, a population1based prospective cohort study of pregnant women and their 
children in Rotterdam, The Netherlands. A total of 9,778 pregnant women were included in the 
study. All children were born between April 2002 and January 2006 7, 8. The children were 
invited at age 5 years with their mothers for examination on the research center by trained 
nurses. Of the 9,778 included pregnant woman 6,690 participated with their children for physical 
examination in the research centre at 5 years of age. The study protocol was approved by the 
Medical Ethical Committee of the Erasmus Medical Centre, Rotterdam (MEC 217.595/2002/20). 
Written informed consent was obtained from all participants. Ocular biometry (AL, corneal 
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curvature (CC) was obtained with a Zeiss IOL1master. Data were collected from right and left 
eyes. Five measurements of axial length were taken of OD and OS and averaged. OD and OS 
measurements were combined to calculate a mean average axial length. Three measurement of 
K1 and K2 were taken of OD and OS, and were averaged. AL/CC ratio was calculated by 
dividing AL(mm) by CC (mm). 
 
'(-
The Western Australian Birth Cohort (Raine) Study is one of the largest ongoing prospective 
cohort studies. It was established in 1989 by recruiting around 2900 pregnant women at 16118 
weeks of gestation in Perth. The original aim of the study was to investigate how events during 
pregnancy and at birth influence the health and wellbeing of the newborns. This cohort has 
gone on to be examined every 2 years by different research groups. At the 20 year follow1up of 
the Raine Cohort were invited to participate in the Raine Eye Health Study (REHS) and 
undertake a comprehensive eye examination. This study was approved by the Human 
Research Ethics Committee at the University of Western Australia. During eye examination, 
post1cycloplegic autorefraction was performed in 1344 participant using the Nidek ARK1510A 
(NIDEK Co.Ltd, Tokyo, Japan) autorefractor. Ocular biometric parameters including axial length 
(AL) and corneal curvature were measured with IOLMaster V.5 (Carl Zeiss Meditec AG, Jena, 
Germany). For AL, five consecutive measurements were taken until the following criteria were 
satisfied: measurements within ± 0.02mm of each other, good waveform – no double peaks, 
acceptable signal1to1noise ratio >2.0. Any measurement outside the mentioned criteria deleted 
and repeated. During keratometry, three measurements within 0.3D within each meridian with 
careful alignment and focus were recorded.  
./
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This study is a school1based population study performed in Singapore. A total of 1,979 children 
in grades 1, 2, and 3 from three schools were recruited from 1999 to 2001 with detailed 
information described elsewhere9. The children were examined on the school premises annually 
by a team of eye care professionals. The GWAS was conducted in a subset of Chinese children 
of 1,116 subjects10. The phenotype used in the cross1sectional study was based on the SE 
measured on the 4th annual examination of the study (children at age 10 to 12 years). Complete 
post1filtering data on measurements and SNP data were available in 994 SCORM children.  
%'
STARS is a population1based survey of Chinese families with children residing in the south1
western and western region of Singapore. Disproportionate random sampling by 61month age 
groups resulted in the recruitment and subsequent eye examination of 3,009 Chinese children 
between May 2006 and November 2008. Details of the study design and methodology have 
been previously described. 11 A total of 1,451 samples from 440 nuclear families underwent eye 
examinations and were included for genome1wide genotyping. In all, 407 children with SE 
measurement had complete post1filtered genotype data.  
%-%
Commencing in the late 2000, 1372 participants were recruited to the Twins Eye Study 
Tasmania through various methods including piggy1backing existing studies where twins had 
been recruited, utilizing the national twin registry, word1of1mouth and local media publicity and 
directly approaching schools 12. Ethical approval was obtained from the Royal Victorian Eye and 
Ear Hospital, the University of Tasmania, the Australian Twin Registry (ATR). Axial length was 
measured using IOLmaster, and corneal curvature was measured using a commercial 
automatic refractor/keratometer (Humphrey1598 Automatic Refractor/Keratometer; Carl Zeiss 
Meditec, Inc., Miami, FL).  In children, buccal swabs or Oragene saliva samples were collected. 
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In adolescents, or when repeat examination was conducted several years later, a blood sample 
was taken and those participants who were now adults signed their own consent. 
	0
The Rotterdam Study is a prospective population‐based cohort study in the elderly living in 
Ommoord, a suburb of Rotterdam, the Netherlands. Details of the study are described 
elsewhere 30. In brief, the Rotterdam Study consists of 3 independent cohorts: RSI, RSII, and 
RSIII. For the current analysis, 5,328 residents aged 55 years and older were included from 
RS1, 2,009 participants aged 55 and older from RS II, and 1,970 aged 45 and older from RS III. 
99% of subjects were of European ancestry. Participants underwent multiple physical 
examinations with regular intervals from 1991 to present . In the fourth visit the examination 
included AL measurement with Lensstar [LS 900]. AL was an average of five measurements of 
OD and OS.  CC was an average of three K1 and K2 measurement of OD and OS. The AL/CC 
ratio was calculated by dividing the mean average AL by the mean average CC. Exclusion 
criteria were bilateral cataract surgery, intra ocular procedures which influence corneal 
curvature or corneal refractive procedures.All measurements in RS‐I1III were conducted after 
the Medical Ethics Committee of the Erasmus University had approved the study protocols and 
all participants had given a written informed consent in accordance with the Declaration of 
Helsinki.   DNA was extracted from blood leucocytes according to standard procedures. 
Genotyping of SNPs was performed using the Illumina Infinium II HumanHap550 chip v3.0 array 
(RS‐I); the HumanHap550 Duo Arrays and the Illumina Human610‐Quad Arrays (RS‐II), and the 
Human 610 Quad Arrays Illumina (RS‐III). Samples with low call rate (0.336), or with sex‐
mismatch were excluded, as were outliers identified by the identity‐by‐state clustering analysis 
(outliers were defined as being >3 s.d. from population mean or having identity‐by‐state 
probabilities >97%). We used genomic control to obtain optimal and unbiased results and 
applied the inverse variance method of each effect size estimated for both autosomal SNPs that 
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were genotyped and imputed in both cohorts. A set of genotyped input SNPs with call rate 
>98%, with minor allele frequency >0.01, and with Hardy‐Weinberg P value >10−6was used for 
imputation. We used the Markov Chain Haplotyping (MACH) package version 1.0.15 software 
(Rotterdam, The Netherlands; imputed to plus strand of NCBI build 36, HapMap release #22) for 
the analyses. For each imputed SNP, a reliability of imputation was estimated as the ratio of the 
empirically observed dosage variance to the expected binomial dosage variance (O/E ratio). 
GWAS analyses were performed using GRIMP. 
-)0(-		
The European Prospective Investigation into Cancer (EPIC) study is a pan1European 
prospective cohort study designed to investigate the aetiology of major chronic diseases.1  
EPIC1Norfolk , one of the UK arms of EPIC, recruited and examined 25,639 participants 
between 1993 and 1997 for the baseline examination.2  Recruitment was via general practices 
in the city of Norwich and the surrounding small towns and rural areas, and methods have been 
described in detail previously.3  Since virtually all residents in the UK are registered with a 
general practitioner through the National Health Service, general practice lists serve as 
population registers.  Ophthalmic assessment formed part of the third health examination and 
this has been termed the EPIC1Norfolk Eye Study.4  In total, 8,623 participants were seen for 
the Eye Study, between 2004 and 2011.  The EPIC1Norfolk Eye Study was carried out following 
the principles of the Declaration of Helsinki and the Research Governance Framework for 
Health and Social Care.  The study was approved by the Norfolk Local Research Ethics 
Committee (05/Q0101/191) and East Norfolk & Waveney NHS Research Governance 
Committee (2005EC07L).  All participants gave written, informed consent. 
Refractive error was measured using a Humphrey Auto1Refractor 500 (Humphrey Instruments, 
San Leandro, California, USA).  Biometry was conducted using non1 contact partial coherence 
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interferometry (IOLMaster V.4, Carl Zeiss Meditech Ltd, Welwyn Garden City, UK). For each 
eye, five measurements of axial length and three measurements of corneal curvature were 
taken. Axial length measurements were repeated if flagged as more than 0.1mm different to the 
others. AL/CR was calculated as described in the primary methods. 
Genotyping was undertaken using the Affymetrix UK Biobank Axiom Array.  SNP exclusion 
criteria included: call rate < 95%, abnormal cluster pattern on visual inspection, plate batch 
effect evident by significant variation in minor allele frequency, and/or Hardy1Weinberg 
equilibrium P < 1017.  Sample exclusion criteria included: DishQC < 0.82 (poor fluorescence 
signal contrast), sex discordance, sample call rate < 97%, heterozygosity outliers (calculated 
separately for SNPs with minor allele frequency >1% and <1%), rare allele count outlier, and 
impossible identity1by1descent values.  Following these exclusions, there were no ethnic 
outliers.  Data were pre1phased using SHAPEIT version 2 and imputed to the Phase 3 build of 
the 1000 Genomes project (October 2014) using IMPUTE version 2.3.2. 
In total, 6051 participants had complete data for both genotypes and phenotypes; their mean 
age was 69 years and 54% were women. 
*	 *!1*2#
The Gutenberg Health Study (GHS) is a population1based, prospective, observational cohort 
study in the Rhine1Main Region in midwestern Germany with a total of 15,010 participants at 
baseline and follow1up after five years. The study sample was recruited from subjects aged 
between 35 and 74 years at baseline exam. Exclusion criteria were insufficient knowledge of the 
German language to understand explanations and instructions, and physical or psychic inability 
to participate in the examinations in the study center. The interdisciplinary study design 
comprises an ophthalmological examination, general and especially cardiovascular 
examinations, psychosomatic evaluation, laboratory tests, and biobanking for proteomic and 
Page 38 of 65
John Wiley & Sons, Inc.
Genetic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
genetic analyses. The study was approved by the Medical Ethics Committee of the University 
Medical Center Mainz and by the local and federal data safety commissioners. According to the 
tenets of the Declaration of Helsinki, written informed consent was obtained from all participants 
prior to entering the study.  
In the first follow1up, the examination included biometry measurement with the Lenstar® LS 900 
(Haag Streit, Wedel, Germany). Axial length (AL) was an average of three measurements of OD 
and OS. Corneal curvature (CC) was an average of three K1 and K2 measurement of OD and 
OS. The AL/CC ratio was calculated by dividing the mean average AL by the mean average CC.  
Within GHS, DNA was extracted from buffy1coats from EDTA blood samples. Genetic analysis 
was conducted in the first 5,000 study participants. For these, 3,463 individuals were genotyped 
in 2008 (GHS 1) and further 1,439 individuals in 2009 (GHS 2). Genotyping was performed for 
GHS 1 and GHS 2 using the Affymetrix Genome1Wide Human SNP Array 6.0 
(http://www.affymetrix.com), as described by the Affymetrix user manual. Genotypes were 
called using the Affymetrix Birdseed1V2 calling algorithm. Individuals with low genotyping call 
rate, a too high level of heterozygosity (hetFDR>0.01)), with sex1mismatches, and with Non1
European ancestry were excluded. After applying standard quality criteria (minor allele 
frequency >1%, genotype call rate >98% and P1value of deviation from Hardy1Weinberg 
equilibrium of >0.0001), 689,634 SNPs in 2996 individuals from GHS1 and 701,418 SNPs in 
1,179 individuals from GHS2 remained for analysis (total 4175). Imputation of missing 
genotypes was performed using the software MACH (v1.0.18.c) and minimac (release 20121031
14) with the reference panel 1000G Phase I Integrated Release Version 2 Haplotypes (20101111
23 data freeze, 2012102114 haplotypes) for each cohort separately. Linear regression analyses 
were performed using ProbABEL (v0.4.1) with age and sex included in the model as covariates. 
.'%'‐3.'%'04
Page 39 of 65
John Wiley & Sons, Inc.
Genetic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
The CROATIA1Korčula and CROATIA1Vis studies performed on Croatian islands, are 
population1based, cross1sectional studies in which adult subjects were recruited for genetic 
studies of many medically1relevant traits including ocular biometrical traits (Vitart et al1IOVS 
51,7371743). The studies received approval from relevant ethics committees in Scotland and 
Croatia and followed the tenets of the Declaration of Helsinki. Keratometry (CC) was measured 
on each eye using a NIDEK Ark30 hand1held autorefractometer/keratometer. Axial length (AL) 
was measured together with other biometric measures using a NIDEK A1scan device (Echoscan 
US11800). Measures on eyes with a history of trauma, intra1ocular surgery, LASIK operations 
were removed. Genotypes were determined using the Illumina BeadStudio software. Samples 
with a call rate below 97 % , potentially mixed samples with excess autosomal heterozygosity or 
gender discrepancy (based on the sex chromosomes genotypes), and ethnic outliers (based on 
principal components analysis of genotypic data), were excluded from the analysis using the 
quality control algorithm implemented in the R package GenABEL. After exclusion of SNP with 
MAF < 0.01, call rate < 98% and HWE deviation p< 1016, samples were pre1phased using 
shapeit v2(ref  O. Delaneau, JF. Zagury, J. Marchini (2013). Improved whole chromosome 
phasing for disease and population genetic studies. Nat Methods. 10(1):516. doi: 
10.1038/nmeth.2307). Imputation was carried out using impute v2 (ref B. N. Howie, P. Donnelly, 
and J. Marchini (2009) A flexible and accurate genotype imputation method for the next 
generation of genome1wide association studies. PLoS Genetics 5(6): e1000529) and the 1,000 
genomes All ancestries phase1 integrated v3 reference panel. The impute2mach GENABEL 
function was used to convert the impute2 outputs to the MACH format that is used in the ABEL 
suite (http://www.genabel.org/packages) and mixed model analyses were run using the 
polygenic functions of the GenABEL package to account for relatedness between individuals 
and fitting independent SNP doses or genetic score as fixed effect together with gender.  
.'%'‐
	
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The CROATIA1Split study, Croatia, is a population1based, cross1sectional study in the 
Dalmatian City of Split that includes 1000 examinees aged 18195. The study received approval 
from relevant ethics committees in Scotland and Croatia and followed the tenets of the 
Declaration of Helsinki. Keratometry and A1scan were performed as described for the other 
CROATIA studies.  
Individuals were genotyped with either the 370CNV1Quadv3 (n=500) or the Illumina 
OmniExpress Exome18v1_A beadchips (n=500). Alleles were called in 
BeadStudio/GenomeStudio using Illumina cluster files. Subjects were excluded if they fulfilled 
any of the following criteria: genotypic call rate <97%, mismatch between reported and 
genotypic sex, unexpectedly low genomic sharing with first degree relatives, excess autosomal 
heterozygosity, or outliers identified by IBS clustering analysis. We excluded SNPs on the basis 
of minor allele frequency (<0.01/monomorphism), HWE (P<10^16), call rate (<97%). The 
samples genotyped with the denser array (Illumina OmniExpress Exome) were first prephased 
and imputed as described for the CROATIA island studies; the phased data was also used as a 
secondary reference panel to complement the 1,000 genomes All ancestries phase1 integrated 
v3 reference panel for the imputation of the samples genotyped on the less dense array. Doses 
derived from imputations for the two halves of the study were then combined for analysis in 
mixed model analyses using the polygenic functions of the GenABEL package to account for 
relatedness between individuals and fitting independent SNP doses or genetic score as fixed 
effects together with gender.  
(
The Nagahama Prospective Genome Cohort for the Comprehensive Human Bioscience dataset
(The Nagahama Study, n=9,809) is a community1based prospective multiomics cohort study 
recruited from the general population living in Nagahma City. The institutional review board and 
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ethics committee of Kyoto University Graduate School and the Faculty of Medicine Ethics 
Committee, the Ad Hoc Review Board of the Nagahama Cohort Project, and the Nagahama 
Municipal Review Board of Personal Information Protection approved the protocols of this study. 
As part of the eye examination, all participants underwent automatic objective refractometry and 
corneal curvature calculation (Autorefractor ARK1530; Nidek, Tokyo, Japan) and axial length 
(AL) measurement (IOL Master; Carl Zeiss, Jena, Germany). The AL/CC ratio was calculated by 
dividing the mean average AL by the mean average CC. DNA was extracted from blood 
leucocytes and genotyping of SNPs was performed for 3,712 samples using at least one of the 
three genotyping platforms, HumanHap610K Quad Arrays, HumanOmni2.5M Arrays, or 
HumanExome Arrays (Illumina, Inc., San Diego, CA, USA).
'
'+)'We are extremely grateful to all the families who took part in this study, the midwives 
for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, 
computer and laboratory technicians, clerical workers, research scientists, volunteers, 
managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust 
(Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This 
publication is the work of the authors and JAG and CW will serve as guarantors for the contents 
of this paper. This research was specifically funded by grant MC_UU_12013/3&4 from the UK 
Medical Research Council and grant Z0GM from the Hong Kong Polytechnic University. GWAS 
data were generated by Sample Logistics and Genotyping Facilities at the Wellcome Trust 
Sanger Institute and LabCorp (Laboratory Corportation of America) using support from 
23andMe.


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,'%5%-%The Brisbane Adolescent Twin Study (BATS) and Twin Eye Study in Tasmania 
(TEST) authors are grateful to Dr Camilla Day and staff for their help in genotyping. The BATS 
and TEST genotyping data were generated and processed by Nicholas G. Martin, Grant W. 
Montgomery, Scott D. Gordon, Dale R. Nyholt, Sarah E. Medland, Brian P. McEvoy, Margaret J. 
Wright, Anjali K. Henders, Megan J. Campbell. The BATS and TEST authors would additionally 
like to thank Jane MacKinnon, Shayne Brown, Jonathan Ruddle, Paul Sanfilippo, Olivia Bigault, 
Colleen Wilkinson, Johan Poulsen, Byoung Sung Chu Yaling Ma, and Julie Barbour for assisting 
with clinical examinations. The Australian Twin Registry was supported by an Australian 
National Health and Medical Research Council (NHMRC) Enabling Grant (2004–2009). We also 
thank the following organisations for their financial support: Clifford Craig Medical Research 
Trust, Ophthalmic Research Institute of Australia (ORIA), American Health Assistance 
Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, 
NHMRC project grant 350415 (2005–2007), Jack Brockhoff Foundation, NEI Project Grant RO1 
EY 018246101 (2007–2010) (PI TLY). Genotyping for part of the BATS and TEST samples was 
funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed 
by CIDR as part of an NEI/NIH project grant. BATS and TEST sample imputation analyses were 
carried out on the Genetic Cluster Computer which is financially supported by The Netherlands 
Scientific Organization (NWO 4801051003). CERA receives Operational Infrastructure Support 
from the Victorian Government. DAM was a recipient of the Pfizer Australia Senior Research 
Fellowship. SM is supported by an Australian Research Council Future Fellowship. YL is 
supported by an Australian National Health and Medical Research Council Early Career 
Fellowship.
%.'%' were funded by grants from the Medical Research Council (UK) and 
from the Republic of Croatia Ministry of Science, Education and Sports (10810803150302); and 
the CROATIA1Korcula genotyping was funded by the European Union framework program 6 
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project EUROSPAN (LSHGCT2006018947). The CROATIA studies acknowledges Biljana 
Andrijević Derk, Valentina Lacmanović Lončar, Krešimir Mandić, Antonija Mandić, Ivan Škegro, 
Jasna Pavičić Astaloš, Ivana Merc, Miljenka Martinović, Petra Kralj, Tamara Knežević and Katja 
Barać1Juretić as well as the recruitment team from the Croatian Centre for Global Health, 
University of Split and the Institute of Anthropological Research in Zagreb for the 
ophthalmological data collection; Peter Lichner and the Helmholtz Zentrum Munchen (Munich, 
Germany), AROS Applied Biotechnology, Aarhus, Denmark and the Wellcome Trust Clinical 
facility (Edinburgh, United Kingdom) for the SNP genotyping  all studies. 
The Generation R Study gratefully acknowledges the contributions of the children 
and their parents, the general practitioners, the hospitals and the midwives and pharmacies in 
Rotterdam. We thank M. Jhamai, M. Ganesh, P. Arp, M. Verkerk, L. Herrera and M. Peters for 
their help in creating, managing and performing quality control for the genetic  database. Also, 
we thank K. Estrada and C. Medina1Gomez for their support in the creation and analysis of 
imputed data. The Generation R Study is conducted by the Erasmus Medical Center in close 
collaboration with the School of Law and the Faculty of Social Sciences of Erasmus University 
Rotterdam, the Municipal Health Service, Rotterdam area, the Rotterdam Homecare Foundation 
and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR1MDC; Rotterdam). 
The generation and management of genotype data for the Generation R Study were performed 
at the Genetic Laboratory of the Department of Internal Medicine at Erasmus Medical Center. 
The Generation R Study is made possible by financial support from the Erasmus Medical 
Center (Rotterdam), the Erasmus University Rotterdam and the Netherlands Organization for 
Health Research and Development (ZonMw; 21000074). The author was supported by the 
following foundations: MaculaFonds, Novartis Fonds, ODAS, LSBS, Oogfonds and ANVVB that 
contributed through UitZicht (grant 2013124). The funding organizations had no role in the 
design or conduct of this research. They provided unrestricted grants. 
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%- The Guangzhou Twin Eye Studies (GTES) was supported by the NSFC (11401600), and 
the Fundamental Research Funds for the Central Universities (15lgpy07). 
%*	 (GHS) is funded through the government of Rheinland1Pfalz 
(„Stiftung Rheinland1Pfalz für Innovation“, contract AZ 9611386261/733), the research programs 
“Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the 
Johannes Gutenberg1University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS 
Medical Systems and Novartis Pharma, including an unrestricted grant for the Gutenberg Health 
Study. Funders were involved in the development of the study design as scientific consultants. 
However, they played no role in data collection, analysis, decision to publish, or preparation of 
the manuscript. 
'(-We are grateful to all the study participants. We also thank the Raine Study and Lions 
Eye Institute (LEI) research staff for cohort coordination and data collection. The core 
management of the Raine Study is funded by The University of Western Australia (UWA), The 
Telethon Institute for Child Health Research, Raine Medical Research Foundation, UWA Faculty 
of Medicine, Dentistry and Health Sciences, Women’s and Infant’s Research Foundation and 
Curtin University. Genotyping was funded by Australian National Health and Medical Research 
Council (NHMRC) project grant 1021105. Support for the REHS was provided by LEI, the 
Australian Foundation for the Prevention of Blindness and the Ophthalmic Research Institute of 
Australia.
	 was supported by the Netherlands Organisation of Scientific Research 
(NWO) (Vidi 91796357); Erasmus Medical Center and Erasmus University, Rotterdam, 
ThNetherlands; Netherlands Organization for Health Research and Development (ZonMw); 
UitZicht; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture 
and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); 
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the Municipality of Rotterdam; the Netherlands Genomics Initiative/NWO; Center for Medical 
Systems Biology of NGI; 73 Lijf en Leven; M.D. Fonds; Henkes Stichting; Stichting Nederlands 
Oogheelkundig Onderzoek; Swart van Essen; Bevordering van Volkskracht; Blindenhulp; 
Landelijke Stichting voor Blinden enSlechtzienden; Rotterdamse Vereniging voor 
Blindenbelangen; OOG; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; the 
Rotterdam Eye Hospital Research Foundation; Topcon Europe; Ada Hooghart, Corina Brussee, 
Riet Bernaerts‐Biskop, Patricia van Hilten, Pascal Arp, Jeanette Vergeer, Marijn Verkerk; 
Sander Bervoets; Daan Loth and Maarten Kooijman.   
%'./The Strabismus, Amblyopia, and Refractive Error Study of Preschool 
Children (STARS) was supported by a NMRC grant (1176/2008). The Singapore Cohort Of the 
Risk factors for Myopia (SCORM) study  was supported by the National Medical Research 
Council, Singapore (NMRC/0795/2005). We acknowledge the Genome Institute of Singapore for 
genotyping all the samples collected from the cohort studies in Singapore. 
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
!
: Previous studies have identified many genetic loci for refractive error and myopia. We 
aimed to investigate the effect of these loci on ocular biometry as a function of age in children, 
adolescents and adults.  
": The study population consisted of three age1groups identified from the international 
CREAM consortium: 5,490 individuals aged <10 years; 5,000 aged 10125 years; and 16,274 
aged >25 years. All participants had undergone standard ophthalmic examination including 
measurements of axial length (AL) and corneal radius (CR). We examined the lead SNP at all 
39 currently known genetic loci for refractive error identified from genome1wide association 
studies (GWAS), as well as a combined genetic risk score (GRS). The beta coefficient for 
association between SNP genotype or GRS versus AL/CR was compared across the 3 age 
groups, adjusting for age, sex, and principal components. Analyses were Bonferroni1corrected. 
 : In the age1group <10 years, 3 loci (	
) were associated with 
AL/CR. In the age1group 10125 years, 4 loci (

) were 
associated; and in adults 20 loci were associated. Association with GRS increased with age; β = 
0.0016 per risk allele ( = 2E108) in <10 years, 0.0033 ( 5E115) in 10125 year1olds, and 
0.0048 ( 1E172) in adults. Genes with strongest effects (, ) had an early effect 
that increased with age.  
: Our results provide insights on the age span during which myopia genes exert 
their effect. These insights form the basis for understanding the mechanisms underlying high 
and pathological myopia. 
 
 
#	: myopia, genetic risk, development, SNPs  


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$% &'($&%
The prevalence of myopia (nearsightedness) has increased dramatically in developed countries 
in recent decades [Bar Dayan, et al. 2005; Vitale, et al. 2009]. Myopia is a complex, 
multifactorial disease with increasing public health burden due to a strong rise worldwide. In 
particular high myopia is associated with blinding complications such as myopic macular 
degeneration, glaucoma and retinal detachment [Curtin and Karlin 1971; McBrien and Gentle 
2003; Saw 2006]. High myopia mostly has its onset in early childhood before age 10 years 
[Fledelius 2000]. 
The eye’s dimensions alter markedly during the peak development phase between birth 
and the late teenage years, ultimately exerting very strong effects on final refractive error (RE) 
in later adult life. A complex process called emmetropisation aims to coordinate ocular 
development, bringing light into clear focus on the retina. Early life myopia is characteristically 
associated with excessive axial length (AL) increase. This results in a mismatch of the optical 
effects of the various refractive components of the eye, resulting in a focal point in front of the 
retina. Such a mismatch can be described by the ratio of AL to corneal radius (CR), AL/CR ratio, 
which has a high correlation with RE [Hashemi, et al. 2013; Ip, et al. 2007] and is independent 
of cycloplegia which may vary between studies.  
Various studies have examined the heritability of myopia showing increased risk for first1
degree relatives of affected individuals [Farbrother, et al. 2004; Guggenheim, et al. 2000] and 
twins [Sanfilippo, et al. 2010; Young, et al. 2007]. Numerous genetic loci that cause familial high 
myopia () have been discovered using linkage analysis [Baird, et al. 2010]. More 
recently, genome wide association studies (GWAS) in large cohorts have been performed to 
identify further determinants for REs in the general population. The first single nucleotide 
polymorphisms (SNPs) identified were near  [Solouki, et al. 2010] and 		[Solouki, 
et al. 2010]. Later many more loci were found in studies of large populations (CREAM; 
23andMe)[Kiefer, et al. 2013; Verhoeven, et al. 2013] [Wojciechowski and Hysi 2013]. 
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All previously published refractive error GWAS studies were performed in cohorts 
enrolling participants aged 25 years and older. We aimed to study the effect size of the 39 
GWAS1identified genetic regions associated with refractive error to date, as a function of age.  
  
")*&'
	
	
We included 18 cohorts from 8 different countries in Europe, Asia and Oceania, with a total of 
5,490 children <10 years, 5,000 individuals of 10125 years, and 16,274 adults, all with 
phenotypic and genome1wide genotypic data available. Age cut off points were based on prior 
knowledge regarding eye growth. The eye has the highest growth rate before the age of 10 
years, and generally does not grow in axial length after age 25 years [Zadnik, et al. 2003]. 
Details on subject recruitment procedures can be found in the supplemental materials. Each 
study participant was genotyped with either an Affymetrix or Illumina SNP array (supplemental 
table I). All studies were conducted according to the Declaration of Helsinki. The studies were 
approved by the local review boards. Written, informed consent for the collection and analysis of 
measurements of all study participants was obtained.  
%!
A total of 39 SNPs were included in this analysis. The SNPs were selected based on their 
known association with RE and myopia in the GWAS carried out by CREAM [Verhoeven, et al. 
2013] and 23andMe [Kiefer, et al. 2013](supplementary table II). An unweighted genetic risk 
score (GRS) was calculated for each participant by summing the dosage of risk alleles (scale 01
2) for all 39 SNPs. The risk score was normally distributed.   
&	
The ocular biometry measurements included AL and CR, and the AL/CR ratio was calculated. 
Multiple measurements of AL and CR were taken of the right eye and left eye, were averaged to 
calculate a mean AL and CR for each eye. The average AL of both eyes was divided by the 
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average CR of both eyes to calculate the AL/CR ratio. Details of the phenotypic assessment 
protocols/instruments used in each study can be found in the supplemental material. 
"+	 
All studies performed linear regression models with each SNP or the GRS as determinants, and 
the AL/CR ratio as outcome. Analyses were adjusted for the potentially confounding effects of 
age and gender, and additionally – to account for ancestry differences within the sample – for 
principal components where applicable. A meta1analysis was performed to estimate the beta 
effects using an inversed variance weighted fixed effect model with METAL [Willer, et al. 2010]. 
Meta1analyses were performed in each age stratum separately, and in combined strata of all 
participants <25 years. Several children measured in TEST (Twins Eye Study Tasmania) and 
GTES (Guangzhou Twin Eye Study) had follow up measurements at an older age; therefore, 
only data from the oldest age were used in the combined analysis. In the Asian studies the 
following SNPs were excluded due to low minor allele frequency (MAF) <0.05 in the Chinese 
population: rs17428076, rs1656404, rs14165, rs13091182, rs12205363, rs11145465, 
rs10882165, and rs17183295.
!		
Loci with significant effects (0.05) were further explored to identify differences in effect of 
early1onset genes (significant loci identified in groups <10 years, 10125 years or the combined 
analysis) and late1onset genes (adult subjects). Data were analysed through the use of 
QIAGEN’s Ingenuity®. 
 Pathway Analysis  (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) and the online 
software tool Database for Annotation, Visualization and Integrated Discovery (DAVID) [Huang 
da, et al. 2009a; Huang da, et al. 2009b]. 
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 )(,
Our study sample of children <10 years comprised 5,490 participants derived from 5 studies; 
one of European ancestry (TEST), three of Asian ancestry (SCORM, STARS, and Guangzhou 
Twins), and one of mixed European, African, and Asian ancestry (Generation R). Our sample of 
individuals aged 10125 years included 5,000 participants derived from 6 studies; 4 of European 
ancestry (TEST, ALSPAC, BATS and RAINE) , and 2 of Asian (STARS, Guangzhou Twins) 
ancestry. Our sample of adults >25 years compromised 16,274 participants derived from 10 
studies; 9 of European ancestry (Croatia Split, 1Kurcula and – Vis study, Gothenburg Health 
Study, EPIC1Norfolk and the Rotterdam Study I1III), and one Asian study (Nagahama). General 
characteristics per study are shown in Table I. 

-
The genetic risk score was associated with a higher AL/CR ratio even in children aged <10 
years (table II), and this association increased in magnitude with older age. Specifically, AL/CR 
increased with each age category from β 0.0019 (SD 0.0003) per risk allele in children <10 
years, to 0.0033 (SD 0.0004) in participants aged 10125 years, to 0.0051 (SD 0.0003) in adults 
(figure I). Only the adult group showed evidence for heterogeneity (heterogeneity 1value 
0.0005) between studies, therefore, meta1analyses for this age category were also performed 
using the random effect model  (β 0.0048; SD 0.0007; supplementary table IV). The variance 
explained by the genetic risk score increased from 0.7% in the children aged 6 from the 
Generation R study, to 3.7% for the adult participants in the RS I1III (Fig II). 

-
In children <10 years, 9/39 loci were significant at P <0.05, and 3/39 were significant after 
correction for multiple1testing for 39 SNPs (P <0.00128). The 3 loci significant after Bonferroni 
correction were in the vicinity of the genes ,  and 	
. The 2 nominally1significant 
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loci with the greatest effect size (beta) were close to the 	
 and 	 genes. The other 
5 loci were near 

 and . Interestingly,the SNP at the 
 locus had a reversed effect from that observed in adult samples, i.e., the risk allele was 
associated with a lower AL/CR ratio. In individuals aged 10 1 25 years, 10/39 loci showed 
nominally significant association with AL/CR ratio, of which 5 survived Bonferroni correction 
( 
and 
!"Five of the 10 SNPs above were already 
nominal significantly associated with AL/CR ratio in children <10 years (
and	!# of the remaining nominally1significant loci, the variant with the greatest 
effect in 10125 year1olds was the SNP at the locus.One variant differed significantly in 
effect between children <10 years and those aged 10125 years. This was the SNP at the 
locus which, as mentioned above, showed an opposite effect to that expected in children aged 
<10 years (Figure III). One of the loci ( !showed evidence for heterogeneity (supplementary 
table III) in effect between study cohorts in the age category 10125 years (Heterogeneity 
0.001). With random effect model the effect of this SNP decreased to β 0.0062 (SE 0.0073; 
0.40)(supplementary table IV). In the combined analysis of all studies <25 years, and 
	 reached Bonferroni adjusted significance; one additional locus ($! showed a 
nominally significant effect for AL/CR ratio. In adults, 31/39 loci showed a significant effect, of 
which 19/39 were Bonferroni significant. All loci, except for % (β 10.0004; SE 0.0019), 
showed an association in the expected direction (i.e. risk allele associated with a higher AL/CR 
ratio). As in 10125 years, one locus significant in adults showed evidence for heterogeneity 
(LOC100506035); with random effect model this locus lost statistical significance 
(supplementary table III and IV). Figure IV displays all estimated effect sizes per age group.  
!		
Pathway analyses were performed to gain insight into the mechanisms for early versus late1
onset eye growth and myopia development. We hypothesized that loci with at least a moderate 
(nominally significant <0.05) effect in children and adolescents most likely had an early onset. 
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Hence, a locus was defined as early onset when nominally significant &'"'!in the group<10 
years of age or the group 10125 yearsand no evidence for heterogeneity (in Figure IV all loci 
above the green line). Loci nominally significant in the adult population without a significant 
effect in the group<10 years of age or the group 10125 yearswere grouped as late onset genes 
(in Figure IV all loci below the green line). We utilized two types of pathway analysis software. 
$	!		.$!/
IPA is a web1based software to analyse and integrate the identified SNPs based on biological 
functions. Analysis were performed in two separate analysis, one analysis with genes with an 
early onset and one analysis with late onset genes. We used the program’s diseases and 
disorder table to identify associated diseases. Genes with an early onset in the age groups <25 
years were enriched in pathways of auditory disease, organismal injury and abnormalities, and 
gastrointestinal disease (at FDR <5%). The genes that were significantly associated in adults 
predisposed to connective tissue disorders, developmental disorder (e.g. microphthalmia; with 
the genes (and  ), and also gastrointestinal disease (supplementary table V).  
'012$'	.'1$'/
The software program DAVID is an online knowledge database to identify overlapping functions  
of genes. We performed the  analyses separately for  early and late onset genes. Using the 
categories defined above, early1onset genes were significantly more than expected annotated  
to ion channels and ion transport. The genes annotated to  these categories were 

	

 and 
. Late onset genes appeared to be significantly  more 
related to neuron differentiation and visual perception. The genes involved in these categories 
were 		 		)			and	(. (supplementary table VI). 
 
'$($&% 
This study identifies the age span during which the known GWAS1identified loci for refractive 
error have their greatest effect. The current meta1analysis suggests that specific loci had their 
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greatest effect in young children (	

), while others reached the greatest 
effect during early teenage years (
). However, most appeared to have 
a gradual effect during the entire age span of myopia development (		( 
		(		 ).  
Strengths of this study were the large sample size, the comparison across 3 distinct age 
categories, and the precision in measurements of ocular biometry. A drawback was the lack of 
complete cycloplegic refraction in children in several studies, which jeopardized valid 
measurements of RE in this age category. Thus, we used AL/CR ratio as an indicator of RE to 
avoid heterogeneity in the outcome. This ratio has a high correlation with RE [Hashemi, et al. 
2013; Ip, et al. 2007] and was available from all studies in the consortium. Another limitation 
was the lack of power to detect statistically significant differences between the age groups for 
most genes. A pooled analysis would have increased statistical power, but raw data from 
individual participants were not available. Ideally, a study using longitudinal data of the same 
children over different age periods would have the best study design for the current analysis.  
Little has been reported on the development and progression of myopia as a function of 
age; however, a number of studies investigated the relationship between development of ocular 
biometry related to age. Until the age of 25 years, corneal curvature, the crystalline lens, and 
axial length all evolve with age, and thereby influence refractive error. The cornea increases in 
radius until preschool age leading to flattening of the corneal curvature and decrease in 
refractive power [Augusteyn, et al. 2012]; the crystalline lens grows until 10 years of age, also 
reducing refractive power [Mutti, et al. 2012; Mutti, et al. 1998]. This decrease in refractive 
power is compensated by axial elongation which increases from 17 mm in newborns [Lim, et al. 
2015] to 23.3 mm in 12113 year olds [French, et al. 2012]. The average AL in emmetropic adults 
is 23.5 mm [Fotedar, et al. 2010; Gordon and Donzis 1985]. The highest growth rate of AL 
occurs in the first years of life and relates to emmetropisation; the growth rate after early teens 
is more gradual but mainly relates to myopisation [Gordon and Donzis 1985]. The exact age at 
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which eye growth stops is not known; generally this occurs before age 20 years, but increase in 
AL has been described up to the age of 25 years in university students [Fledelius 2000; 
Midelfart, et al. 1992].  
One of the key detected GWAS1identified loci for refractive error is on chromosome 15 
near the  gene, that encodes a gap junction protein known as CX36. This protein not only 
processes cone1to1cone and cone1to1rod signals [Lee, et al. 2003] but also directs signaling 
between other retinal cells [Feigenspan, et al. 2001; Hidaka, et al. 2004]. This cell1to1cell 
communication appears to be under regulation of light exposure and dopamine [Bloomfield and 
Volgyi 2009], two factors that have an established role in eye growth and myopia development. 
Our data suggest that  has an early1onset, indicating that altered retinal cell signaling, 
perhaps via reduced light exposure and low dopamine levels, may be a first step in myopia 
development. As expected, some early1onset genes also had a reported role in eye 
development. Knockout of a gene encoding the large extracellular glycoprotein laminin1
α2; causes growth retardation including smaller eyes with compressed cellular layers [Gupta, et 
al. 2012]. Mutations in the serine protease gene 	  cause a severe decrease of AL 
leading to microphthalmia [Nair, et al. 2011].  Another developmental gene is  an 
enhancer1binding factor required for embryonic stem cell specification [Luo, et al. 2015]. This 
gene may be important for development of retinal architecture, as it is known to be involved in 
differentiation and proliferation of retinal progenitor cells [Watabe, et al. 2011], and development 
of retinal ganglion cell trajectories [Herrera, et al. 2003]. Strikingly, several other genes involved 
in eye development, such as  ), and  , did not show an early onset but were 
more significant after the age of 10 years. Other early1onset genes were ion channels such as 

, a potassium channel present in cone and rod photoreceptors [Zhang, et al. 2011], and 

, a calcium channel present in photoreceptors [Xiao, et al. 2007]. 	
 has as yet 
an unknown role in myopia development. It encodes the γ subunit of the embryonal 
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acetylcholine receptor, which is widely expressed in the retina [Hruska, et al. 1978; Hutchins 
and Hollyfield 1985], and is associated with multiple pterygium syndrome [Vogt, et al. 2012].   
Several remarkable patterns of effect were notable. For instance, the lead SNPs at the 
		, and ( locishowed an opposite effect in children <10 years than 
in those who were older. This is not uncommon in biology, as such a trajectory has also been 
described for the locus in relation to body mass index in children [Sovio, et al. 2011]. 
Interestingly, gene expression studies of  in chickens showed that mRNA of this gene in 
the retinal pigment epithelium is up1 or down1regulated depending on the location of the image 
plane [Zhang, et al. 2012]. When the image was focused behind the retina, mRNA was 
downregulated and the vitreous chamber enlarged. This underscores a bidirectional role for 
 in modulation of eye growth.   
Most genes had a late onset. ( has a similar function to  as it is also responds 
to optical defocus with bidirectional regulation of eye growth [Zhang, et al. 2013].   is a 
DNA1binding homeobox and has a SIX domain, which binds downstream effector molecules. It 
is known to influence eye size in zebrafish with knocked down  expression [Iglesias, et al. 
2014]. Other genes play a less obvious role in myopiagenesis. MYO1D is involved in membrane 
trafficking in the recycling pathway and expressed in oligodendrites [Benesh, et al. 2012]. 
		a gene encoding a nuclear receptor1directing photoreceptor differentiation, is known to 
activate and generate S1opsin [Jia, et al. 2009; Srinivas, et al. 2006]. DLX1 belongs to the DLX 
family of homeobox transcription factors, and produces GABAergic interneurons during 
embryonic development.  
In conclusion, our study suggests that only a small proportion of the currently known 
GWAS1identified loci for RE exert their full effect at a young age. Furthermore, some of the 
pathways previously1identified by GWAS meta1analyses [Verhoeven, et al. 2013] can now be 
separated into early1 and late1onset pathways. For example, genes coding for ion channels 
typically had an early onset, while genes related to connective tissue and visual feedback 
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mechanisms appeared to become more important at a later age. As the currently known genes 
play only a minor role in early1onset myopia, we question whether this type of myopia is caused 
by common variants in other genes, or whether rare variants with large effects determine early1
onset. Future research may shed more light on genes for early1onset myopia, and unravelling 
these genes will open up strategies for prevention of high myopia.  
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Table I Participating studies and characteristics stratified per age group 
*GTES= Guangzhou Twin Eye Study, RS I-III = Rotterdam Study I-III, GHS=Gutenberg Health Study 
 
345	
	 % ,6 .'7/ .'/ -089
STARS 207 2.99 (0.150; 2.76 – 3.46) 5.45 (2.11) 47.3 
Generation R 3,874 2.87 (0.083; 2.38 – 3.90) 6.18 (0.51) 50.3 
SCORM 898 3.02 (0.112; 2.63 – 3.45) 7.48 (0.87) 47.7 
TEST 166 2.94 (0.101; 2.65 – 3.25) 7.53 (1.21) 52.4 
GTES 345 2.97 (0.100; 2.62 – 3.45) 8.73 (0.79) 50.1 
Total :0;<5 
45+=:	
STARS 96 3.23 (0.127; 2.95 – 3.60) 12.23 (1.7) 58.3 
GTES 699 3.13 (0.147; 2.58 – 3.82) 14.83 (1.2) 52.9 
TEST 182 2.99 (0.108; 2.68 – 3.51) 15.16 (4.0) 60.4
ALSPAC 1,996 2.99 (0.099; 2.57 – 3.52) 15.46 (0.3) 53.6 
BATS 983 3.03 (0.106; 2.67 – 3.82) 19.07 (3.2) 53,8
RAINE 1,044 3.05 (0.104; 2.63 – 3.54) 20.04 (0.4) 48.9 
Total :0555 
>=:	
Nagahama 2,762 3.13 (0.153; 2.62 – 3.86) 52.05 (13.8) 49.0 
Croatia1Split 730 3.02 (0.128; 2.38 – 3.90) 52.16 (13.0) 61.2 
Croatia Korcula 832 2.99 (0.203; 2.26 – 5.73) 56.62 (13.3) 64.7 
Croatia1Vis 573 2.99 (0.121; 2.50 – 3.83) 55.93 (13.8) 60.4 
GHS 2 936 3.07 (0.160; 2.50 – 4.01) 59.26 (10.6) 50.0 
GHS 1 1,919 3.06 (0.151; 2.30 – 3.88) 60.17 (10.7) 47.1 
EPIC1Norfolk 6,051 3.05 (0.146; 2.42 – 3.95) 68.9 (8.0) 54.3 
RS I1III 2,471 3.05 (0.143; 2.43 – 3.86) 70.02 (8.8) 53.6 
Total 4?0=@; 
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Table II Effect size of myopia related genes in age groups <10 years, 10-25 years, 25> years 
    
<10 years 10 - 25 years Combined >25 years 
Variant Chr Gene RA Beta (SE) P Beta (SE) P Beta (SE) P Beta (SE) P 
Allele Score - - - 0.0019 (0.0003) 10^-11 0.0033 (0.0004) 10^-15 0.0024 (0.0002) 10^-24 0.0051(0.0003) 10^-72 
rs1652333 1 CD55 G 0.0033 (0.0017) 0.05 0.0006 (0.0024) 0.80 0.0026 (0.0014) 0.07 0.0084(0.0017) 10^-6 
rs4373767 1 ZC3H11B T 0.0010 (0.0017) 0.55 0.0032 (0.0023) 0.16 0.0019 (0.0014) 0.16 0.0053(0.0017) 0.002 
rs17412774 2 PABPCP2 A 0.0007 (0.0017) 0.69 0.0010 (0.0023) 0.67 0.0008 (0.0014) 0.57 0.0063(0.0017) 10^-4 
rs17428076 2 DLX1 C 0.0017 (0.0021) 0.43 0.0029 (0.0027) 0.28 0.0024 (0.0017) 0.16 0.0073(0.0021) 10^-4 
rs1898585 2 PDE11A T 0.0022 (0.0019) 0.26 0.0050 (0.0029) 0.09 0.0034 (0.0017) 0.04 0.0057(0.0021) 0.007 
rs1656404 2 PRSS56 A 0.0073 (0.0024) 0.002 0.0067 (0.0033) 0.04 0.0069 (0.0019) 10^-4 0.0079(0.0024) 0.001 
rs1881492 2 CHRNG T 0.0086 (0.0024) 10^-4 0.0039 (0.0031) 0.21 0.0064 (0.0020) 0.001 0.0085(0.0022) 10^-5 
rs14165 3 CACNA1D G 0.0035 (0.0020) 0.08 0.0082 (0.0026) 0.001 0.0055 (0.0016) 0.001 0.0055(0.0020) 0.005 
rs13091182 3 ZBTB38 G 0.0008 (0.0020) 0.69 -0.0001 (0.0024) 0.98 0.0007 (0.0015) 0.66 -0.0004(0.0019) 0.83 
rs9307551 4 LOC100506035 A 0.0007 (0.0019) 0.70 0.0037 (0.0026) 0.16 0.0020 (0.0016) 0.20 0.0051(0.0020) 0.008 
rs5022942 4 BMP3 A 0.0014 (0.0018) 0.44 -0.0016 (0.0026) 0.54 0.0007 (0.0015) 0.63 0.0006(0.0020) 0.78 
rs7744813 6 KCNQ5 A 0.0050 (0.0017) 0.004 0.0081 (0.0023) 10^-4 0.0060 (0.0014) 10^-5 0.0066(0.0018) 10^-4 
rs12205363 6 LAMA2 T 0.0041 (0.0041) 0.31 0.0138 (0.0046) 0.003 0.0094 (0.0031) 0.003 0.0229(0.0036) 10^-10 
rs7829127 8 ZMAT4 A 0.0025 (0.0020) 0.22 0.0019 (0.0028) 0.49 0.0025 (0.0017) 0.13 0.0072(0.0021) 0.001 
rs7837791 8 TOX G 0.0029 (0.0016) 0.06 0.0083 (0.0022) 10^-4 0.0050 (0.0013) 10^-4 0.0042(0.0017) 0.012 
rs4237036 8 CHD7 T 0.0001 (0.0018) 0.96 0.0032 (0.0024) 0.18 0.0013 (0.0014) 0.37 0.0058(0.0018) 0.001 
rs11145465 9 TJP2 A 0.0035 (0.0022) 0.11 0.0027 (0.0028) 0.33 0.0029 (0.0017) 0.09 0.0062(0.0021) 0.004 
rs7042950 9 RORB G 0.0028 (0.0019) 0.14 0.0031 (0.0026) 0.24 0.0027 (0.0016) 0.08 0.0071(0.0020) 10^-4 
rs7084402 10 BICC1 G 0.0035 (0.0016) 0.03 0.0066 (0.0023) 0.004 0.0050 (0.0013) 10^-4 0.0074(0.0017) 10^-6 
rs6480859 10 KCNMA1 T 0.0040 (0.0018) 0.02 0.0037 (0.0023) 0.10 0.0040 (0.0014) 0.004 0.0015(0.0017) 0.38 
rs745480 10 RGR G 0.0007 (0.0016) 0.67 0.0021 (0.0022) 0.34 0.0011 (0.0013) 0.40 0.0055(0.0017) 0.001 
rs10882165 10 CYP26A1 T 0.0012 (0.0018) 0.49 0.0002 (0.0024) 0.93 0.0007 (0.0014) 0.61 0.0011(0.0018) 0.54 
rs1381566 11 LRRC4C G 0.0026 (0.0020) 0.21 0.0040 (0.0034) 0.23 0.0028 (0.0018) 0.12 0.0093(0.0022) 10^-5 
rs2155413 11 DLG2 A 0.0022 (0.0017) 0.18 0.0027 (0.0022) 0.23 0.0023 (0.0013) 0.09 0.0021(0.0017) 0.21 
rs11601239 11 GRIA4 C 0.0011 (0.0016) 0.50 0.0027 (0.0022) 0.22 0.0014 (0.0013) 0.30 0.0055(0.0017) 0.001 
rs3138144 12 RDH5 G 0.0020 (0.0021) 0.35 0.0039 (0.0027) 0.16 0.0028 (0.0017) 0.10 0.0045(0.0019) 0.02 
rs12229663 12 PTPRR A -0.0023 (0.0019) 0.21 0.0046 (0.0026) 0.08 0.0000 (0.0016) 1.00 0.0069(0.0019) 10^-4 
rs8000973 13 ZIC2 C 0.0058 (0.0017) 10^-4 0.0058 (0.0023) 0.01 0.0059 (0.0014) 10^-5 0.0027(0.0017) 0.10 
rs2184971 13 PCCA A 0.0008 (0.0016) 0.61 0.0006 (0.0023) 0.80 0.0009 (0.0014) 0.48 0.0021(0.0017) 0.21 
rs66913363 14 BMP4 G -0.0025 (0.0017) 0.15 0.0040 (0.0024) 0.10 0.0006 (0.0014) 0.68 0.0047(0.0017) 0.006 
rs1254319 14 SIX6 A 0.0007 (0.0017) 0.68 0.0044 (0.0024) 0.07 0.0017 (0.0014) 0.22 0.0054(0.0018) 0.002 
rs524952 15 GJD2 A 0.0069 (0.0016) 10^-5 0.0068 (0.0023) 0.003 0.0067 (0.0013) 10^-7 0.0122(0.0016) 10^-14 
rs4778879 15 RASGRF1 G 0.0018 (0.0017) 0.29 0.0033 (0.0023) 0.15 0.0019 (0.0014) 0.17 0.0051(0.0017) 0.002 
rs17648524 16 A2BP1 C 0.0018 (0.0018) 0.33 0.0079 (0.0024) 0.001 0.0039 (0.0015) 0.01 0.0077(0.0019) 10^-5 
rs2969180 17 SHISA6 A 0.0035 (0.0016) 0.03 0.0017 (0.0023) 0.46 0.0027 (0.0014) 0.05 0.0079(0.0017) 10^-6 
rs17183295 17 MYO1D T -0.0033 (0.0023) 0.16 0.0009 (0.0030) 0.76 -0.0018 (0.0018) 0.33 0.0089(0.0023) 10^-4 
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Values are betas (SE) and P-values, from linear regression models adjusted for sex, age and principal components if applicable meta-analysed 
with inversed variance meta-analysis in METAL. Bold: P <0.05. 
rs4793501 17 KCNJ2 T 0.0029 (0.0016) 0.08 0.0001 (0.0022) 0.95 0.0019 (0.0013) 0.16 0.0041(0.0017) 0.015 
rs12971120 18 CNDP2 A 0.0002 (0.0019) 0.93 0.0048 (0.0026) 0.07 0.0017 (0.0015) 0.27 0.0024(0.0019) 0.22 
rs235770 20 BMP2 T -0.0043 (0.0018) 0.02 0.0121 (0.0025) 10^-6 0.0008 (0.0015) 0.60 0.0043(0.0017) 0.013 
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9$A Association between genetic risk score and myopia in the three age groups  
9$$A Association between non1weighted genetic risk score and AL/CR ratio in children and adults. 
9$$$A Increased effect on AL/CR ratio with age for  gene. 
9$1A Distribution of effects on AL/CR ratio per myopia1related gene in three age groups 

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Thank you for pointing this out. We have expanded this part in the result section page 8 in lines 15 – 50.  
Verhoeven VJ, Hysi PG, Wojciechowski R, Fan Q, Guggenheim JA, Hohn R, MacGregor S, Hewitt AW, Nag 
A, Cheng CY and others. 2013. Genome-wide meta-analyses of multiancestry cohorts identify 
multiple new susceptibility loci for refractive error and myopia. Nat Genet 45(3):314-8. 
Zadnik K, Manny RE, Yu JA, Mitchell GL, Cotter SA, Quiralte JC, Shipp M, Friedman NE, Kleinstein R, 
Walker TW and others. 2003. Ocular component data in schoolchildren as a function of age and 
gender. Optom Vis Sci 80(3):226-36. 
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